Delivery Order SPE2DB20D2014-SPE2DB25FC64B
- Not listed
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the procurement of 0.5 mL ampules of 1 mg Vitamin K-1. The contract has a firm fixed price of $1,333.86 and an ultimate completion date of March 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of phytonadione 10 mg/mL ampules, a type of vitamin K medication, with a ceiling value of $2,032.35 and a period of performance extending to June 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,774.99 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,811.29 delivery order contract is for the supply of Phytonadione 10 mg/mL ampoules, a type of injectable vitamin K medication. The contract is not set aside and is a firm fixed-price agreement with a performance period through June 26, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.32 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes (0.5 mL units). This is a firm fixed-price delivery order with no set-aside designation, executed on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This federal contract award, valued at $13,246.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vitamin K-1 10 mg/ml ampules. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $20,559.12. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $2,716.90, with completion targeted for July 21, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The U.S. Department of Defense Medical Supply Chain awarded a $2,701.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Phytonadione 10 mg/ml ampules, with an ultimate completion date of August 4, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Phytonadione 1 mg/0.5 ml syringe, a vitamin K medication, with a ceiling value of $1,425.42 and a period of performance through May 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC64BDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Vitamin K-1 10 mg/ml ampules, with a contract ceiling value of $8,170.26. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award carries no set-aside designation, indicating competitive procurement. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. Vitamin K-1, a critical pharmaceutical product used for coagulation management and treatment of vitamin K deficiency in military medical settings, reflects the essential nature of AmerisourceBergen's federal supply chain role supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 8/4/25 |